Apple didn't issue RSUs to employees last year? Sure.

10% rolling ESOP is pretty standard public company fare. Can you show me a company that doesn't have one?

I'm no fan of Bruce's bonus but he hasn't been granted any stock options, yet.

And, these are not dilutive unless the PPS appreciates so it aligns management with PPS performance.

Egregious. Haha.

Not to throw rocket fuel on this fire but the $400 thousand compensation is not for a full time job. He is CEO of another company.

http://martellotech.com/about-us/management-team/

Agreed. Whoever though up that name is the village idiot. Someone should ask on the next investor call.

I think we have a good estimate collectively of the revenue growth to be reported this quarter but we'll likely see increased expenses from Tweed Farms. It's growing to 10x the capacity and that expansion wasn't really underway for the reporting period of the last Qs.

Good news is that we shouldn't see the cost structure grow anymore significantly from that point onward.

Quarterly results out soon. Seems like some investor(s) are bailing before they hit OR maybe it's that Tweed hasn't gotten its oil license yet while 5 others have. What's up with dat?

The original public filing statement I think said that Rifici and Linton had less than 50% ownership of 1 Hershey.

+1.

Tweed's quarters have been getting released on the 25/26th of the 2nd month following mont end so I would expect an Aug 25th release of Q1 ending June 30 this go around.

If they can sell at $15/g, that's great. Means tweed is well priced.

http://news.gc.ca/web/article-en.do?mthd=tp&crtr.page=1&nid=997359&crtr.tp1D=980

*drop mic*

So, you weren't happy... You called the CEO... He actually calls you back... And instead of talking to him, you choose to complain here.

Clearly they don't care enough to call you back. Oh wait... Got it.

So... You're paying less than $5 per gram, yes? Sounds like you got your promise.

They never promised you $4 per gram.

I think they just clarified their program but I agree they should have kept a $5 strain.

MMAR and underground grows can't compete with scaled up LPs on price - even eith all the red tape and extra compliance costs LPs have. When Tweed has 500 thousand sq ft in production, they'll be able to beat dispensary pricing. If they would want to or should is another matter...

I don't recall Tweed promising $5 before discount. They promised to sell 10% of products at $5 or less. I bet if you ask them, they will be able to show that they have always maintained that.

Aphriq wholesaled product to someone. organigram makes sense. So much for only organic production.

Great info on export and pending edibles announcement. Good work!

The discount to BED stock is justified because even though the chcsnce of a deal falling through is small, if it did fall through, BED price will plummet.

It's in the FS

Who has the order # spreadsheet? Wondering what the amount of orders was for Q5 so that we can see what the average revenue per order is.

April 2 was 1646x. I can't find Dec order #.

Looks like Tweed wants to uplist to TSX but board soon. Getting their audited FS done in 90 days for the TSX non-venture requirement certain sends the right signal.

20,000 messages. Thanks all (most) for the great discussion.

Tilray is beginning its fade...

I think Organigram is an insignificant player who is still overvalued. Mettrum has size but what is compelling about their offering? I'm guessing they are paying kickbacks as I don't see why patients would choose them.

Actually, there are 2 Ryan's at least. The Ryan grower you linked to and Ryan the master grower
http://www.tweed.com/blogs/blog/10479181-meet-ryan-our-master-grower

Not the same guy. Ryan Douglas is Tweed's head grower.

I can't tell if you are doing a Bobby Bonno impression or have gone to the land of the trolls

Statistically, acquirers almost always overpay. It's the price of doing a deal.

I am not a fan of the acquisition.

Bed has good pharma brand and I don't disagree with the synergies BUT a stock deal is about relative value of shares and Tweed is just coming into major sales growth after building capacity for over a year whereas Bed is just starting domestic production and will see a slower ramp up.

So, I believe the value spread would widen if not for the acquisition and Twd could have bought Bed for half the price in 6 months time as TWD stock appreciates and Bed drops (if not for the deal).

In other words, TWD has overpaid.

Bed irradiates all their product. That hides a lot of growing imperfections. I would suspect Tweed has a better product but Bed has more stable strains which are needed for clinical trials.

I expect clinical trials and/or international partnership news to flow in the fall once this deal closes.

Zekulin is now President of Tweed as of about a month

Bruce is speaking at the Harvard Club in NY right now I hear and said Tweed has 1/3 of all MMPR customers.

Tell that to Amazon, Salesforce, every other widely successful high growth company in the first x years in business.

With no dum dums and no replies, I count almost 60% less posts. Now that was noise. Upwards and onwards.

OMG thank you. No more ding dong replies!

$600k of extra revenue increase minimum each quarter is plenty to erase the deficit quickly enough.

Even if that holds true, 3000 new LP patients with 20% to Tweed = 600 new patients.

If average order per patient is about 1.5g/day, that's 135g per quarter per patient in sales at $7.5/g = $1,000 per new patient per quarter so +$600k in revenue every quarter.

That would be just fine IMHO but I think Tweed is capturing more. Like someone else said, many LPs will max out. Tweed is ensuring it will never again run out of supply.

It's far more expensive to lose a potential customer due to lack of supply as it is to have some extra inventory go bad but I'm sure they have a wholesale plan for that extra product as well.

Tweed for the win.

Pretty much

The only thing "killing" Tweed, if you mean getting to profitability, is that Tweed is betting on very big market growth. Building scale incurs losses.

As long as Tweed continues to expand operations, they will post losses. I think expansion is the right move but expanding means taking on additional overhead and staff with a big lag for revenues to eventually offset those additional costs to eventually get to profit.

I think the biggest growing platform wins and Tweed will have the biggest IMHO.

That looks right.
- Average order size that is consistent over 2 quarters at just under $160 so no reason for that to change much
- currently 110 orders per day in mid-May (and mid-quarter) so it's reasonable to assume that 110 orders per day could also be the average for calendar Q2

That equals a $1.6 million revenue as a baseline. I'd like to see TWD hit $2mm in Q2 which will happen if we see the daily order count climb a bit faster in early June IMHO.